Pyxis Oncology, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Pyxis Oncology, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2021 to Q3 2024.
  • Pyxis Oncology, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 11, 2024 was 59.5M shares, a 34.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 59.5M +15.1M +34.2% Nov 11, 2024 10-Q 2024-11-12
Q2 2024 58.9M +19.4M +49.1% Aug 13, 2024 10-Q 2024-08-14
Q1 2024 58.1M +21.2M +57.2% Mar 20, 2024 10-K 2024-03-21
Q3 2023 44.3M +9.23M +26.3% Nov 6, 2023 10-Q 2023-11-07
Q2 2023 39.5M Aug 9, 2023 10-Q 2023-08-11
Q1 2023 37M +4.14M +12.6% Mar 21, 2023 10-K/A 2023-05-10
Q3 2022 35.1M +2.33M +7.12% Nov 1, 2022 10-Q 2022-11-01
Q1 2022 32.8M Mar 29, 2022 10-K 2022-03-29
Q3 2021 32.8M Nov 12, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.